• 대한한의학회지
• /
• 제25권2호
• /
• pp.98-109
• /
• 2004

Objectives : To evaluate the anti-tumor and synergic effect of Soonkiwhajungtang with doxorubicin. Methods : The inhibitory concentration (IC), $IC_{50}$ and $IC_{90}$ of single use of doxorubicin and Soonkiwhajungtang with their concomitant treatment against MKN-45 (human stomach carcinoma) cell line were observed using MTT (microculture tetrazolium test) assay. In addition, their anti-tumor effects were also observed in xenograft nude mice models against the MKN-45 cell line. Results : Soonkiwhajungtang has only minimal direct anti-tumor effect against MKN-45 cell line but it reduced general depressed signs induced by implantation of the tumor cell lines and increased the total WBC and lymphocyte numbers. Conclusions : It is considered or expected that Soonkiwhajungtang extract reduces the critical toxicity of doxorubicin and has favorable synergic anti-tumor effect when administered concomitantly with doxorubicin.

• 대한한의학회지
• /
• 제25권2호
• /
• pp.9-21
• /
• 2004

Objectives : To evaluate the anti-tumor and synergic effect of Bojungikkeehapdaechilki-tang (BJDC) with doxorubicin. Methods : The inhibitory concentration (IC), $IC_{50}{\;}and{\;}IC_{90}$ of single use of doxorubicin and BIDC with their concomitant treatment against Colon-26 (murine rectum carcinoma) cell line were observed using MTT (microculture tetrazolium test) assay. In addition, their anti-tumor effects were also observed in xenograft nude mice models against Colon-26 cell line. Results : BJDC had only minimal direct anti-tumor effect against Colon-26 cell line but it reduced general depressed signs induced by implantation of the tumor cell lines and increased the total WBC and lymphocyte numbers. Conclusions : It is considered or expected that BJDC extract is reducing the critical toxicity of doxorubicin and has favorable synergic anti-tumor effect when administered conconitently with doxorubicin.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권7호
• /
• pp.4267-4271
• /
• 2013

Background: As natural medicines in Asia, curcumin and triptolide extracted from different drug plants have proven to possess anticancer potential and widely used for anti-cancer research. The present study attempted to clarify that curcumin and triptolide synergistically suppress ovarian cancer cell growth in vitro. Methods: To test synergic effects, cell viability and apoptosis were analyzed after curcumin and triptolide combination treatment on ovarian cancer cell lines. Synergistic effects on apoptosis induction were determined by lactate dehydrogenase (LDH) leakage assay, intracellular reactive oxygen species (ROS) assay, mitochondrial membrane potential (MMP) loss assay and flow cytometry analysis. Critical regulators of cell proliferation and apoptosis related were analyzed by qRT-PCR and Western blotting. Results: We showed that the combination of curcumin and triptolide could synergistically inhibit ovarian cancer cell growth, and induce apoptosis, which is accompanied by HSP27 and HSP70, indicating that HSP27 and HSP70 play the important role in the synergic effect. Conclusions: From the result present here, curcumin and triptolide combination with lower concentration have a synergistic anti-tumor effect on ovarian cancer and which will have a good potential in clinical applications.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권9호
• /
• pp.5243-5248
• /
• 2013

Background: Triptolide, extracted from the herb Tripteryglum wilfordii Hook.f that has long been used as a natural medicine in China, has attracted much interest for its anti-cancer effects against some kinds of tumours in recent years. Artesunate, extracted from the Chinese herb Artemisia annua, has proven to be effective and safe as an anti-malarial drug that possesses anticancer potential. The present study attempted to clarify if triptolide enhances artesunate-induced cytotoxicity in pancreatic cancer cell lines in vitro and in vivo. Methods: In vitro, to test synergic actions, cell viability and apoptosis were analyzed after treatment of pancreatic cancer cell lines with the two agents singly or in combination. The molecular mechanisms of apoptotic effects were also explored using qRT-PCR and Western blotting. In vivo, a tumor xenograft model was established in nude mice, for assessment of inhibitory effects of triptolide and artesunate. Results: We could show that the combination of triptolide and artesunate could inhibit pancreatic cancer cell line growth, and induce apoptosis, accompanied by expression of HSP 20 and HSP 27, indicating important roles in the synergic effects. Moreover, tumor growth was decreased with triptolide and artesunate synergy. Conclusion: Our result indicated that triptolide and artesunate in combination at low concentrations can exert synergistic anti-tumor effects in pancreatic cancer cells with potential clinical applications.

• Archives of Pharmacal Research
• /
• 제20권4호
• /
• pp.379-383
• /
• 1997

Cyclosporin A, an potent immunosuppressant, has been known to be one of the modulators of drug resistance as well as a cytostatic drug. Despite many attempts to basic or clinical application of cyclosporin A, there are few reports on the inhibition of brain tumor cells. In the present experiment, the possibility of cyclosporin A as synergic adjuvant was investigated by MTT assay, $[^{3}H]$ thymidine uptake and through flowcytometric anaysis. Sole treatment of cyclosporin A on the CRT and CH235-MG glioma cell line revealed dose dependent cytotoxicity within a range of tested dose. Combined treatment of cyclosporin A with ACNU, BCNU and hydroxyurea on various glioma cancer cell line led to a significant synergistic cytotoxicity as well as inhibition of DNA synthesis with dose-dependency. In addition, cyclosporin A alone or combined treatment caused discernible changes of cell cycle in the tested cells. These data provide that cyclosporin A could potentiate the effect of nitrosourea compounds in vitro on human glioma cells.

• Journal of Welding and Joining
• /
• 제31권1호
• /
• pp.26-32
• /
• 2013

Recently, welding technology of nonferrous metals which were difficult to implement by arc welder has become available through digitalization of arc welding machine. Among them, the welding quality improvement of aluminum welding is very noticeable. These results increase the arc stability by controlling arc current and voltage waveform precisely, and control wire feed speed by synchronizing with arc current which the feed rate of filler wire is controlled by a precise motor control of servomotor and not by a simple constant speed feeding. Not only through the hardware digitalization of arc welding machine but also through advance of software of arc welding, it became possible to implement a certain level of welding quality by a simple operation. These led to CMT welding process implementation which requires low heat input than current arc welding and highly increased the applicability of the aluminum welding.

• 한국약용작물학회지
• /
• 제14권2호
• /
• pp.63-69
• /
• 2006

The methanolic (MeOH) extract of A. fruticosa bark, which showed immune-regulatory activities, was separated to purify an active compared by means of a multi-stage column chromatography. This resulted in the isolation and characterization of an isoflavone glycoside named 4', $6-Dimethoxyisoflavone-7-O-{\beta}-D-glucopyranoside$. Immuno-regulatory activities of the crude extract of Amorpha fruticosa LINNE bark were compared with that of an isoflavone glycoside (4', $6-dimethoxyisoflavone-7-O-{\beta}-D-glucopyranoside$). The crude methanolic extract of A. fruticosa and purified single compound showed 16% of relatively low cytotoxicity at a maximum concentration of 1.0 g/L in cultivated normal human lung cell line (HEL299). Cell growth of human T cells was increased up to 15%, 0.5 g/L of the crude extract added group. This was higher than a single compound added one. On the other hand, specific production rates of IL-6 and $TNF-{\alpha}$ from T cell were higher in the purified compound treat group ($0.82{\times}10^{-4}\;pg/cell$ and $1.08{\times}10^{-4}\;pg/cell$, respectively), compared to 0.5 g/L of the crude extract added group ($0.65{\times}10^{-4}\;pg/cell$ and $0.84{\times}10^{-4}\;pg/cell$, respectively). In addition, the growth of NK-92MI cells incubated with the crude extract was higher up to 56% over the cells grown with a single compound (0.5 g/L). In overall, the crude extract showed relatively higher immuno-regulatory activities compared with a single compound, probably due to the synergic effect given by other substances existed in the crude extract. Even though the siolated compound stimulated higher secretion of cytokines from human T cells.

• 한국가금학회지
• /
• 제37권1호
• /
• pp.63-68
• /
• 2010

본 시험은 산란계 사료 내 사과박 발효물의 첨가가 산란계 생산성, 계란 품질 및 장내 미생물 변화에 미치는 영향을 조사하기 위하여 57주령 Hy-Line을 200수를 공시하여 5처리, 4반복, 반복당 10수씩 배치하여 10주간 사양 시험을 실시하였다. 시험구는 무첨가구(Control, C)와 산란계 사료 내 생균제 0.1% 첨가구(T1), 사과박 발효물 1.0% 첨가구(T2), 계피0.1%첨가구(T3) 및 계피를 첨가한 사과박 발효물 1.0% 첨가구(T4)로 처리구를 나누어 시험을 실시하였다. 시험 전기간 동안 총 산란율에서는 각 처리구간 유의적인 차이는 인정되지 않았으나 대조구와 비교하였을 때 생균제 및 발효 사과 부산물 첨가구에서 6.1% 개선되는 결과를 나타내었다. 계피 0.1% 첨가구에서는 무첨가구 대비 4.5% 개선되는 결과를 나타내었다. 시험 기간 동안 계란 품질 조사 결과 전체 처리구에서 유의적인 차이는 없었으나, 신선도의 경우 무첨가구와 비교 시 발효 사과 부산물 처리구에서1.2%의 개선 효과를 나타내어 안전 양계 산물 생산에 대한 가능성을 나타내었다. 시험 전 기간 동안 혈액 생화학 및 혈구에 대해 처리구간 유의적인 차이는 나타나지 않았다. 결과적으로 산란계 사료 내 발효 사과 부산물의 첨가 급여는 산란계에 있어 생산성에 대해 개선 효과를 가지며, 향후 곡물 수급의 불안정 및 양계 분야에 대체 자원의 필요성을 고려할 때 농산부산물을 활용한다는 점에서 충분한 가능성을 시사한 결과라 할 수 있다.